SANUWAVE Health (SANUWAVE Health) Debt-to-Equity

: -0.71 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

SANUWAVE Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $29.96 Mil. SANUWAVE Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.49 Mil. SANUWAVE Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-43.18 Mil. SANUWAVE Health's debt to equity for the quarter that ended in Dec. 2023 was -0.71.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for SANUWAVE Health's Debt-to-Equity or its related term are showing as below:

SNWV' s Debt-to-Equity Range Over the Past 10 Years
Min: -3.46 Med: -0.75 Max: -0.61
Current: -0.71

During the past 13 years, the highest Debt-to-Equity Ratio of SANUWAVE Health was -0.61. The lowest was -3.46. And the median was -0.75.

SNWV's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.2 vs SNWV: -0.71

SANUWAVE Health Debt-to-Equity Historical Data

The historical data trend for SANUWAVE Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-0.69

-1.28

-0.72

-0.95

-0.71

SANUWAVE Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																-0.95	-0.74	-0.73	-0.58	-0.71

Competitive Comparison

For the Medical Devices subindustry, SANUWAVE Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SANUWAVE Health Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Debt-to-Equity falls into.

SANUWAVE Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

SANUWAVE Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(29.962	+	0.492)	/	-43.178
	=	-0.71

SANUWAVE Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(29.962	+	0.492)	/	-43.178
	=	-0.71

SANUWAVE Health (OTCPK:SNWV) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

SANUWAVE Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SANUWAVE Health (SANUWAVE Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

11495 Valley View Road, Eden Prairie, MN, USA, 30024

Website

https://www.sanuwave.com

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Executives

Andrew Walko	officer: President	11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
James E Besser	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p.	director, other: Director by Deputization	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank	director	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price	director	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh	officer: President	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii	10 percent owner	200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski	director	99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc.	director	3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom	officer: Interim CFO	11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli	director, officer: Chief Executive Officer	510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins	officer: Chief Financial Officer	11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino	director	PO BOX 376, LOBBY L., ANN ARBOR MI 48105